|
|
|
|
|
|
At Monogram Biosciences, Inc., our mission is to improve healthcare by advancing
individualized medicine through the discovery and commercialization of innovative
products that guide and improve the treatment of serious viral infections and cancer.
The Company’s products are designed to help doctors optimize treatment regimens
for their patients that lead to better outcomes and reduced costs. The Company’s
technologies are also used by pharmaceutical and biopharmaceutical companies to
develop new and improved anti-viral therapeutics and vaccines as well as targeted
cancer therapeutics.
We view scientific collaboration as an important component of our past and future
success and the fulfillment of our mission. Since the Company was founded in
1996, we have encouraged and supported productive collaborations with renowned
investigators representing industry, government and academic institutions in their
diverse pursuit of basic, applied, translational and clinical research interests.
The products of these collaborations have contributed
to significant advancements in the scientific and clinical understanding of antiviral
drug susceptibility and resistance, viral replication, viral fitness and infectivity, antiviral
immune responses and escape, viral diversity and evolution, genetic recombination,
oncogene activation and transformation, cellular signal transduction, anticancer drug
susceptibility and resistance, and disease prognosis.
Qualified investigators interested in establishing scientific collaborations with Monogram
can inquire about collaborative opportunities or submit research concepts by contacting
csedik@monogrambio.com or by submitting an online information request.
Collaborative proposals will be assessed, prioritized and approved based
on the merits of the proposal using the following criteria:
- Research plan
- Investigator qualifications
- Research environment and facilities
- Suitability of requested materials
- Patient confidentiality and scientific/clinical ethics
Access to Monogram data/materials/services necessary to support collaborations
established for each study are based on the conditions of material transfer agreements
(MTA) agreeable to Monogram and the collaborator and his/her institution. The specific
content of an MTA is developed on a case-by-case basis, but typically includes sections
that address the following terms and components of the collaboration:
- Confidentiality and disclosure of data and related information
- Use of materials and data
- Terms and conditions for presentation and publication
- Acknowledgement of data/materials/services
- Inventorship of and rights to intellectual property
|
|
 |
|
